Histone acetyltransferases interact with and acetylate p70 ribosomal S6 kinases in vitro and in vivo

被引:28
作者
Fenton, T. R. [1 ]
Gwalter, J. [1 ]
Ericsson, J. [3 ]
Gout, I. T. [1 ,2 ]
机构
[1] UCL, Res Dept Struct & Mol Biol, London WC1E 6BT, England
[2] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, UA-03143 Kiev, Ukraine
[3] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, S-75124 Uppsala, Sweden
基金
英国生物技术与生命科学研究理事会;
关键词
S6; kinase; Acetyltransferase; HDAC inhibitor; CREB-BINDING PROTEIN; TRANSCRIPTIONAL COACTIVATOR; CELL-GROWTH; PHOSPHORYLATION; P300; BETA; CLONING; CANCER; UBIQUITINATION; TRANSLATION;
D O I
10.1016/j.biocel.2009.11.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 70 kDa ribosomal protein S6 kinases (S6K1 and 56K2) play important roles in the regulation of protein synthesis, cell growth and survival. S6Ks are activated in response to mitogen stimulation and nutrient sufficiency by the phosphorylation of conserved serine and threonine residues. Here we show for the first time, that in addition to phosphorylation, S6Ks are also targeted by lysine acetylation. Following mitogen stimulation, S6Ks interact with the p300 and p300/CBP-associated factor (PCAF) acetyltransferases. S6Ks can be acetylated by p300 and PCAF in vitro and S6K acetylation is detected in cells expressing p300. Furthermore, it appears that the acetylation sites targeted by p300 lie within the divergent C-terminal regulatory domains of both S6K1 and S6K2. Acetylation of S6K1 and 2 is increased upon the inhibition of class I/II histone deacetylases (HDACs) by trichostatin-A, while the enhancement of S6K1 acetylation by nicotinamide suggests the additional involvement of sirtuin deacetylases in S6K deacetylation. Both expression of p300 and HDAC inhibition cause increases in S6K protein levels, and we have shown that S6K2 is stabilized in cells treated with HDAC inhibitors. The finding that S6Ks are targeted by histone acetyltransferases uncovers a novel mode of crosstalk between mitogenic signalling pathways and the transcriptional machinery and reveals additional complexity in the regulation of S6K function. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 50 条
  • [41] Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases
    Fruergaard, Marlene Uglebjerg
    Nielsen, Christine Juul Faelled
    Kjeldsen, Cecilia Rosada
    Iversen, Lars
    Andersen, Jacob Lauwring
    Nissen, Poul
    LIFE SCIENCE ALLIANCE, 2023, 6 (05)
  • [42] Involvement of phosphoinositide-3-kinase and p70 S6 kinase in regulation of proliferation of rat lactotrophs in culture
    Kawashima, K
    Yamakawa, K
    Arita, J
    ENDOCRINE, 2000, 13 (03) : 385 - 392
  • [43] Activation of S6K1 (p70 ribosomal protein S6 kinase 1) requires an initial calcium-dependent priming event involving formation of a high-molecular-mass signalling complex
    Hannan, KM
    Thomas, G
    Pearson, RB
    BIOCHEMICAL JOURNAL, 2003, 370 : 469 - 477
  • [44] Suppression by HSP90 inhibitors of BMP-4-stimulated osteoprotegerin synthesis in osteoblasts: Attenuation of p70 S6 kinase
    Kawabata, Tetsu
    Otsuka, Takanobu
    Fujita, Kazuhiko
    Kainuma, Shingo
    Yamamoto, Naohiro
    Kuroyanagi, Gen
    Sakai, Go
    Matsushima-Nishiwaki, Rie
    Kozawa, Osamu
    Tokuda, Haruhiko
    MOLECULAR MEDICINE REPORTS, 2017, 16 (06) : 8507 - 8512
  • [45] BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo
    Sapkota, Gopal P.
    Cummings, Lorna
    Newell, Felicity S.
    Armstrong, Christopher
    Bain, Jennifer
    Frodin, Morten
    Grauert, Matthias
    Hoffmann, Matthias
    Schnapp, Gisela
    Steegmaier, Martin
    Cohen, Philip
    Alessi, Dario R.
    BIOCHEMICAL JOURNAL, 2007, 401 : 29 - 38
  • [46] Arginine and leucine regulate p70 S6 kinase and 4E-BP1 in intestinal epithelial cells
    Ban, H
    Shigemitsu, K
    Yamatsuji, T
    Haisa, M
    Nakajo, T
    Takaoka, M
    Nobuhisa, T
    Gunduz, M
    Tanaka, N
    Naomoto, Y
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2004, 13 (04) : 537 - 543
  • [47] AT7867 Is a Potent and Oral Inhibitor of AKT and p70 S6 Kinase That Induces Pharmacodynamic Changes and Inhibits Human Tumor Xenograft Growth
    Grimshaw, Kyla M.
    Hunter, Lisa-Jane K.
    Yap, Timothy A.
    Heaton, Simon P.
    Walton, Mike I.
    Woodhead, Steven J.
    Fazal, Lynsey
    Reule, Matthias
    Davies, Thomas G.
    Seavers, Lisa C.
    Lock, Victoria
    Lyons, John F.
    Thompson, Neil T.
    Workman, Paul
    Garrett, Michelle D.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (05) : 1100 - 1110
  • [48] The phosphoinositide 3-kinase and p70 S6 kinase regulate long-term potentiation in hippocampal neurons
    Raymond, CR
    Redman, SJ
    Crouch, MF
    NEUROSCIENCE, 2002, 109 (03) : 531 - 536
  • [49] Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathway
    Al-Shami, R
    Sorensen, ES
    Ek-Rylander, B
    Andersson, G
    Carson, DD
    Farach-Carson, MC
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2005, 94 (06) : 1218 - 1233
  • [50] Regulation of mTOR and p70 S6 kinase by the muscarinic M4 receptor in PC12 cells
    Chan, Grace P. W.
    Wu, Eddy H. T.
    Wong, Yung H.
    CELL BIOLOGY INTERNATIONAL, 2009, 33 (02) : 230 - 238